AU2001259507A1 - Compounds and methods for the diagnosis and treatment of ehrlichia infection - Google Patents

Compounds and methods for the diagnosis and treatment of ehrlichia infection

Info

Publication number
AU2001259507A1
AU2001259507A1 AU2001259507A AU5950701A AU2001259507A1 AU 2001259507 A1 AU2001259507 A1 AU 2001259507A1 AU 2001259507 A AU2001259507 A AU 2001259507A AU 5950701 A AU5950701 A AU 5950701A AU 2001259507 A1 AU2001259507 A1 AU 2001259507A1
Authority
AU
Australia
Prior art keywords
diagnosis
compounds
treatment
methods
ehrlichia infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259507A
Inventor
Raymond L. Houghton
Michael J. Lodes
Patricia D. Mcneill
Steven G Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/693,542 external-priority patent/US6673356B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001259507A1 publication Critical patent/AU2001259507A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001259507A 2000-05-08 2001-05-04 Compounds and methods for the diagnosis and treatment of ehrlichia infection Abandoned AU2001259507A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US56661700A 2000-05-08 2000-05-08
US09566617 2000-05-08
US09/693,542 US6673356B1 (en) 1997-03-21 2000-10-20 Compounds and methods for the diagnosis and treatment of ehrlichia infection
US09693542 2000-10-20
US09798042 2001-03-02
US09/798,042 US20020068343A1 (en) 1997-03-21 2001-03-02 Compounds and methods for the diagnosis and treatment of ehrlichia infection
PCT/US2001/014518 WO2001085949A2 (en) 2000-05-08 2001-05-04 Compounds and methods for the diagnosis and treatment of ehrlichia infection

Publications (1)

Publication Number Publication Date
AU2001259507A1 true AU2001259507A1 (en) 2001-11-20

Family

ID=27415994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259507A Abandoned AU2001259507A1 (en) 2000-05-08 2001-05-04 Compounds and methods for the diagnosis and treatment of ehrlichia infection

Country Status (5)

Country Link
US (1) US20020068343A1 (en)
EP (1) EP1282711A2 (en)
AU (1) AU2001259507A1 (en)
CA (1) CA2408344A1 (en)
WO (1) WO2001085949A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
CN101970463A (en) 2007-09-21 2011-02-09 艾德克斯实验室公司 Methods and compositions for detection of ehrlichia chaffeensis (vlpt)
US7741059B2 (en) * 2007-09-21 2010-06-22 Idexx Laboratories, Inc. Methods and compositions for detection of Ehrlichia chaffeensis (p120)
WO2009070507A2 (en) 2007-11-27 2009-06-04 Idexx Laboratories, Inc. Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma
CA2739796C (en) 2008-10-08 2018-11-06 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
US9133525B2 (en) 2012-01-26 2015-09-15 Luc Montagnier Detection of DNA sequences as risk factors for HIV infection
US20180372742A1 (en) * 2015-12-10 2018-12-27 Immport Therapeutics, Inc. Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277381B1 (en) * 1997-03-21 2001-08-21 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6207169B1 (en) * 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection

Also Published As

Publication number Publication date
WO2001085949A2 (en) 2001-11-15
US20020068343A1 (en) 2002-06-06
CA2408344A1 (en) 2001-11-15
WO2001085949A3 (en) 2002-06-27
EP1282711A2 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AU2001280702A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AU6579498A (en) Compounds and methods for the diagnosis and treatment of (ehrlichia) infection
AUPQ893200A0 (en) Medical residue treatment
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001284857A1 (en) Surgical instrumentation and method for treatment of the spine
AU2001241963A1 (en) Improved medical procedure
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
EP1144639A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2077099A (en) Medical endoscope infection prevention device for only one use
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
HUP0105310A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001282277A1 (en) Treatment of mycobacterial infection
AU7455300A (en) The band combined medical treatment of ion
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AU2001253560A1 (en) Methods of treatment
AU2001261416A1 (en) Compounds and methods for the diagnosis and treatment of babesia microti infection